These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8301680

  • 1. Ocular manifestations in bone marrow transplantation.
    Spires R.
    J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ocular complications in high-dose chemoradiotherapy and marrow transplantation.
    Jack MK, Hicks JD.
    Ann Ophthalmol; 1981 Jun; 13(6):709-11. PubMed ID: 7020552
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E, Ołdakowska-Jedynak U, Brydak-Godowska J, Paczek L, Kecik D.
    Transplant Proc; 2006 Jun; 38(1):292-4. PubMed ID: 16504728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.
    Mori A, Hashino S, Imamura M, Kahata K, Kawakami H, Shibata M, Kobayashi S, Tanaka J, Asaka M.
    Bone Marrow Transplant; 1998 Mar; 21(6):615-7. PubMed ID: 9543066
    [Abstract] [Full Text] [Related]

  • 14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [Abstract] [Full Text] [Related]

  • 18. Progressive corneal vascularization caused by graft-versus-host disease.
    Mohammadpour M.
    Cornea; 2007 Feb; 26(2):225-6. PubMed ID: 17251819
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 20. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A, Rózycki R.
    Klin Oczna; 2005 Aug; 107(4-6):280-6. PubMed ID: 16118939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.